| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone |
| Available forms, composition and doses of NEE 1 / 35: |
| N / A |
| NEE 1 / 35 medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Lexis Laboratories |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Modicon | Ethinyl Estradiol; Norethindrone | Janssen; Ortho McNeil Pharmaceuticals |
| N.E.E. | Ethinyl Estradiol; Norethindrone | LPI |
| Necon 0.5 / 35 | Ethinyl Estradiol; Norethindrone | Watson Pharmaceuticals |
| Necon 1 / 35 | Ethinyl Estradiol; Norethindrone | Watson Pharmaceuticals |
| Necon 10 / 11 | Ethinyl Estradiol; Norethindrone | Watson Pharmaceuticals |
| Nelova 0.5 / 35E | Ethinyl Estradiol; Norethindrone | Warner Chilcott |
| Nelova 1 / 35E | Ethinyl Estradiol; Norethindrone | Warner Chilcott |
| Nelova 10 / 11 | Ethinyl Estradiol; Norethindrone | Warner Chilcott |
| Neocon | Ethinyl Estradiol; Norethindrone | Janssen |
| Neocon 1 / 35 | Ethinyl Estradiol; Norethindrone | Janssen |